SCHEMBL3357784

SCHEMBL3357784

COc1ccc(C2COc3cc(O)c(O)cc3C2=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 5/20 1.00
ALOX15 P16050 4/20 1.00
CYP19A1 P11511 9/20 0.67
KCNH2 Q12809 1/20 0.58
TRPV1 Q8NER1 1/20 0.58
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
RECQL P46063 1/20 0.49
CYP3A4 P08684 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069507 0.85 ALOX12 (0.74) ALOX12ALOX15CYP19A1KCNH2TRPV1
SCHEMBL29559241 0.85 ALOX12 (0.74) ALOX12ALOX15CYP19A1KCNH2TRPV1
SCHEMBL5503331 0.85 CYP19A1 (0.84) ALOX12ALOX15CYP19A1KCNH2TRPV1
SCHEMBL572236 0.84 ALOX12 (1.00) ALOX12ALOX15CYP19A1
SCHEMBL30217587 0.84 ALOX12 (1.00) ALOX12ALOX15CYP19A1
SCHEMBL14628580 0.83 ALOX12 (0.71) ALOX12ALOX15CYP19A1KCNH2TRPV1
SCHEMBL30951649 0.82 ALOX12 (0.73) ALOX12ALOX15CYP19A1KCNH2TRPV1
SCHEMBL705945 0.81 CYP19A1 (1.00) ALOX12ALOX15CYP19A1KCNH2TRPV1
Dihydrobiochanin A SCHEMBL30217535 0.81 ALOX12 (0.67) ALOX12ALOX15CYP19A1KCNH2TRPV1
SCHEMBL2071244 0.78 ALOX12 (0.64) ALOX12ALOX15CYP19A1KCNH2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 ALOX12 3429/4885ALOX15 3682/4885CYP19A1 529/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 ALOX12 3429/4885ALOX15 3682/4885CYP19A1 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.